Egypt vs Georgia: HIV-positive TB patients on ART (antiretroviral therapy)
Egypt
100.0%
in 2024
Georgia
100.0%
in 2024
Egypt rank
1st
Georgia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Egypt
- Georgia
How they compare
Egypt currently reports 100.0% against 100.0% in Georgia, a difference of 0.0%.
The two have swapped places 3 times across 19 shared years of data; in 2006 it was Egypt ahead.
Egypt ranks 1st and Georgia ranks 1st of 144 countries.
Egypt has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Egypt | Georgia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 64.8% | 35.2% | Egypt |
| 2010s | 100.0% | 89.8% | 10.2% | Egypt |
| 2020s | 100.0% | 96.6% | 3.4% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Egypt or Georgia?
- Egypt, at 100.0% against 100.0% in Georgia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Egypt and Georgia?
- 0.0%, with Egypt ahead.
- How many years of comparable data are there for Egypt and Georgia?
- 19 years are reported by both, from 2006 to 2024.
- How do Egypt and Georgia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Egypt ranks 1st and Georgia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.